These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32507806)

  • 1. [Successful management of acquired factor V deficiency developing shortly after induction of hemodialysis].
    Matsumoto A; Ogawa Y; Osaki T; Souri M; Yanagisawa K; Ishizaki T; Naito C; Ishikawa T; Miyazawa Y; Shimizu H; Inoue M; Hayakawa M; Murakami M; Ichinose A; Handa H
    Rinsho Ketsueki; 2020; 61(5):445-450. PubMed ID: 32507806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired Factor V Deficiency Associated with CFPM Administration.
    Yamanishi M; Nishimi Y; Usui M; Miki K; Imashuku S
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrence of acquired factor V inhibitor after four years of remission].
    Akashi N; Ogawa Y; Yanagisawa K; Osaki Y; Shimizu H; Ishizaki T; Inoue M; Murakami M; Souri M; Ichinose A; Handa H
    Rinsho Ketsueki; 2019; 60(1):46-50. PubMed ID: 30726824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis.
    Ogawa H; Souri M; Kanouchi K; Osaki T; Ohkubo R; Kawanishi T; Wakai S; Morikane K; Ichinose A
    Int J Hematol; 2019 Feb; 109(2):214-220. PubMed ID: 30446942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune coagulation factor V/5 deficiency during chronic disseminated intravascular coagulation].
    Ishimori N; Wakabayashi M; Sakurai K; Suda A; Souri M; Osaki T; Ichinose A
    Rinsho Ketsueki; 2023; 64(2):113-118. PubMed ID: 36990730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy.
    Mihara M; Ogawa Y; Nagasaka M; Kobayashi N; Shimizu H; Shinozawa K; Fukutake K; Inoue M; Murakami M; Handa H
    Acta Haematol; 2020; 143(5):486-490. PubMed ID: 31563916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired Factor V Inhibitors in a Patient with End-stage Renal Disease.
    Kitazawa A; Misawa H; Nagahori K; Koda R; Yoshino A; Kawamoto S; Takeda T
    Intern Med; 2016; 55(23):3505-3509. PubMed ID: 27904118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease.
    Katsuren E; Kohagura K; Kinjyo T; Zamami R; Nakamura T; Oshiro N; Sunagawa Y; Omine K; Kudo Y; Shinzato Y; Osaki T; Souri M; Ichinose A; Yamazato M; Ishida A; Ohya Y
    CEN Case Rep; 2023 Feb; 12(1):91-97. PubMed ID: 35943699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acquired factor V inhibitor].
    Yamada S; Asakura H
    Rinsho Ketsueki; 2020; 61(7):791-798. PubMed ID: 32759567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
    Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
    Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence of acquired factor V inhibitor during antibiotic therapy for a surgical wound infection].
    Okabe T; Ueno H; Fujita S; Kagoo T; Boku S; Yano T; Yokoyama A
    Rinsho Ketsueki; 2018; 59(8):1007-1011. PubMed ID: 30185699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy.
    Takahashi H; Fuse I; Abe T; Yoshino N; Aizawa Y
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):87-93. PubMed ID: 12544735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin.
    Tarantino MD; Ross MP; Daniels TM; Nichols WL
    J Pediatr Hematol Oncol; 1997; 19(3):226-31. PubMed ID: 9201145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.
    Sridharan M; Fylling KA; Ashrani AA; Chen D; Marshall AL; Hook CC; Cardel LK; Nichols WL; Pruthi RK
    Thromb Res; 2018 Nov; 171():14-21. PubMed ID: 30227314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion management of factor V deficiency: three case reports and review of the literature.
    Gavva C; Yates SG; Rambally S; Sarode R
    Transfusion; 2016 Jul; 56(7):1745-9. PubMed ID: 27125565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Coagulation Factor V Inhibitor That Was Successfully Treated with Oral Corticosteroid Therapy.
    Yokota Y; Inatomi O; Nakagawa M; Kakuda K; Hiroe K; Sakai S; Osaki R; Iwasa M; Kawahara M; Kito K; Andoh A; Bamba H
    Intern Med; 2021 Aug; 60(16):2663-2666. PubMed ID: 34121013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of asymptomatic acquired factor V inhibitor after the administration of antibiotics].
    Kinjo Y; Yoshimura K; Suzuki T; Shinozawa K; Nakasone K; Yoshimata T; Nishihira M; Henzan E
    Rinsho Ketsueki; 2014 Nov; 55(11):2311-5. PubMed ID: 25501413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan.
    Ichinose A; Osaki T; Souri M
    Semin Thromb Hemost; 2022 Mar; 48(2):206-218. PubMed ID: 34942668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate.
    Bulato C; Novembrino C; Anzoletti MB; Spiezia L; Gavasso S; Berbenni C; Tagariello G; Farina C; Nardini I; Campello E; Peyvandi F; Simioni P
    Haemophilia; 2018 Jul; 24(4):648-656. PubMed ID: 29578313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
    de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
    Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.